David Gordon
2019 - Aclaris Therapeutics
In 2019, David Gordon earned a total compensation of $1.4M as Former Chief Medical Officer at Aclaris Therapeutics.
Compensation breakdown
Non-Equity Incentive Plan | $113,680 |
---|---|
Salary | $406,000 |
Stock Awards | $843,592 |
Other | $8,904 |
Total | $1,372,176 |
Gordon received $843.6K in stock awards, accounting for 61% of the total pay in 2019.
Gordon also received $113.7K in non-equity incentive plan, $406K in salary and $8.9K in other compensation.
Rankings
In 2019, David Gordon's compensation ranked 7,778th out of 13,971 executives tracked by ExecPay. In other words, Gordon earned more than 44.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,778 | 44th |
Manufacturing | 3,050 | 46th |
Chemicals And Allied Products | 1,149 | 48th |
Drugs | 981 | 48th |
Pharmaceutical Preparations | 729 | 48th |
Gordon's colleagues
We found three more compensation records of executives who worked with David Gordon at Aclaris Therapeutics in 2019.
News
Aclaris Therapeutics CEO Neal Walker's 2021 pay jumps 326% to $6.9M
April 21, 2022
Coffee Holding Co CEO Andrew Gordon's 2021 pay slips 10% to $380K
February 28, 2022
Coffee Holding Co CEO Andrew Gordon's 2020 pay falls 66% to $421K
March 29, 2021
Aclaris Therapeutics CEO Neal Walker's 2019 pay falls 28% to $3.2M
April 23, 2020
Coffee Holding Co CEO Andrew Gordon's 2019 pay jumps 220% to $1.2M
February 28, 2020
Coffee Holding Co Secretary David Gordon's 2018 pay rises 2% to $389K
February 28, 2019